TY  - GEN
AU  - Yin,Xiu-Feng
AU  - Ma,Qiu-Ling
AU  - Mu,Qi-Tian
AU  - Shao,Li
AU  - Wang,Sha-Sha
AU  - Meng,Hai-Tao
AU  - Xu,Wei-Lai
AU  - Wang,Yun-Gui
AU  - Chen,Zhi-Mei
AU  - Chen,Fei-Fei
AU  - Jin,Jie
TI  - Outcome prediction by the transcript level of BCR-ABL at 3 months in patients with chronic myeloid leukemia treated with imatinib--a single institution historical experience
SN  - 1873-5835
PY  - 2014///1118
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Benzamides
KW  - Child
KW  - Female
KW  - Fusion Proteins, bcr-abl
KW  - genetics
KW  - Humans
KW  - Imatinib Mesylate
KW  - Kaplan-Meier Estimate
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Piperazines
KW  - Proportional Hazards Models
KW  - Pyrimidines
KW  - Retrospective Studies
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.leukres.2014.07.003
ER  -